What is the story about?
Persistent Systems' share price fell 4.6 per cent on Wednesday, a day after the company reported its third-quarter results for the financial year 2026.
The company reported a mixed Q3 performance on a quarter-on-quarter basis, with net profit declining 6.8 per cent to Rs 439.4 crore even as revenue rose 5.5 per cent to Rs 3,778.2 crore. Global brokerage firm Nuvama has noted that it has hiked its target price for the company to Rs 7,700 from its earlier target of Rs 7,000 and has maintained a 'Buy' call for the stock.
Persistent Systems Stock
The company's share price fell 4.6 per cent to hit an intraday low of Rs 6,048 apiece, and it pared losses to trade 3.39 per cent lower as of 10:06 AM
Persistent Systems carries a total market capitalisation of nearly Rs 96,140 crore, while its one‑year price range spans from a low of Rs 5,708 to a high of Rs 6,976
The stock's Relative Strength Index was 24. Notably, an RSI above 70 indicates that the stock is overbought, and below 30 indicates the stock is oversold. Meanwhile, 30 to 70 indicates a neutral zone, with 50 often indicating no strong trend.
Persistent Systems Q3 Result
The company's net profit fell 6.8 per cent to Rs 439.4 crore. However, revenue rose 5.5 per cent to Rs 3,778.2 crore.
During the quarter, Persistent registered a one-time impact of Rs 89 crore from the implementation of the new Labour Codes.
Persistent Systems recorded order bookings of $674.5 million in total contract value (TCV) and $501.9 million in annual contract value (ACV) for the quarter ended December 31, 2025.
The company added 487 employees in Q3 FY26, bringing its total staff count to 26,711.
The board has also approved an interim dividend of Rs 22 per equity share of face value Rs 5 each for the financial year 2025-26, rewarding shareholders. Moreover, the company has also approved the issuance of 1,100,000 equity shares of Rs 5 each to the ESOP Trust of the company.
Brokerage on Persistent Systems
Nuvama on Persistent Systems
- Maintain Buy with a target price of Rs 7,700 (earlier Rs 7,000)
- Q3FY26 delivered strong, broad-based growth across verticals, led by Healthcare, BFSI, and Hi-tech
- Deal momentum remained healthy, with robust TCV and ACV
- Margin expansion continued despite wage hikes, driven by Al-led platform monetisation, operating leverage, and cost optimisation
- Book
- Management highlighted Al platforms as a key driver of both margins and growth
- EPS estimates were upgraded on the back of a higher margin outlook and rolled-forward valuation
- Maintain a positive stance despite premium valuations
